Literature DB >> 9619484

Natural killer cell proliferation induced by anti-NK1.1 and IL-2.

A Reichlin1, W M Yokoyama.   

Abstract

NKR-P1 molecules are involved in natural killing of certain tumour targets. Indeed, the NK1.1 (NKR-P1C) molecule is the most specific serological marker on murine NK cells in C57BL/6 mice. Previous studies of NKR-P1 have indicated that anti-NKR-P1 mAb induced NK cells to kill otherwise insensitive targets, NK cell phosphoinositol turnover and Ca++ flux but it was not previously known if all NK cells were activated. In this study we report that immobilized anti-NK1.1 also specifically induced proliferation as measured by thymidine incorporation. The response required low doses of IL-2 for a synergistic effect. Cells stimulated with anti-NK1.1 + IL-2 displayed characteristic cytolytic activity against a NK-sensitive tumour target, YAC-1. However, anti-NK1.1-stimulated cells displayed delayed proliferation kinetics, heterogeneity of the expression of the very early antigen marker, CD69, and altered expression of the Ly-49 family members when compared to NK cells activated by high concentrations of IL-2. Taken together, these data demonstrate that immobilized anti-NK1.1 triggers only a subpopulation of NK cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619484     DOI: 10.1046/j.1440-1711.1998.00726.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  9 in total

1.  A Listeria-derived polypeptide promotes in vivo activation of NK cells for antitumor therapy.

Authors:  Amber L Ortiz; Laurel L Lenz
Journal:  Immunohorizons       Date:  2017-06-26

Review 2.  Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function.

Authors:  Sunil K Joshi; Mark L Lang
Journal:  Int Immunopharmacol       Date:  2013-06-22       Impact factor: 4.932

3.  IL-2 mediates NK cell proliferation but not hyperactivity.

Authors:  Richa Sharma; Asmita Das
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

4.  Novel method for isolating untouched rat natural killer cells with higher purity compared with positive selection and fluorescence-activated cell sorting.

Authors:  Aurélie Poli; Nicolaas H C Brons; Wim Ammerlaan; Tatiana Michel; François Hentges; Martha Chekenya; Jacques Zimmer
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

5.  Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.

Authors:  A Nicol; M Nieda; Y Koezuka; S Porcelli; K Suzuki; K Tadokoro; S Durrant; T Juji
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

6.  Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma.

Authors:  Vanaja Konduri; Dali Li; Matthew M Halpert; Dan Liang; Zhengdong Liang; Yunyu Chen; William E Fisher; Silke Paust; Jonathan M Levitt; Qizhi Cathy Yao; William K Decker
Journal:  Oncoimmunology       Date:  2016-07-22       Impact factor: 8.110

7.  Nonstochastic coexpression of activation receptors on murine natural killer cells.

Authors:  H R Smith; H H Chuang; L L Wang; M Salcedo; J W Heusel; W M Yokoyama
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

8.  Natural Killer Cells Integrate Signals Received from Tumour Interactions and IL2 to Induce Robust and Prolonged Anti-Tumour and Metabolic Responses.

Authors:  Nidhi Kedia-Mehta; Chloe Choi; Aisling McCrudden; Elisabeth Littwitz-Salomon; Proinnsias G Fox; Clair M Gardiner; David K Finlay
Journal:  Immunometabolism       Date:  2019-09-25

9.  Dissection of agonistic and blocking effects of CD200 receptor antibodies.

Authors:  Munir Akkaya; Marie-Laure Aknin; Billur Akkaya; A Neil Barclay
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.